Enclomiphene can increase libido indirectly by raising testosterone levels in men with low testosterone. It does this by stimulating the body’s own hormone production rather than replacing it with external testosterone. However, enclomiphene doesn’t have a direct effect on sexual desire the way testosterone itself does. The libido improvement depends on how low your testosterone was to begin with and how much it rises during treatment.
How Enclomiphene Raises Testosterone
Enclomiphene works by blocking estrogen receptors in the brain, specifically in the hypothalamus. Normally, estrogen signals the brain to slow down testosterone production through a feedback loop. By blocking that signal, enclomiphene tricks the brain into thinking estrogen levels are low, which triggers the pituitary gland to release more of the hormones (LH and FSH) that tell the testes to produce testosterone.
The testosterone increase can be substantial. In a pharmacokinetic study of men with secondary hypogonadism, those taking 25 mg daily started with an average total testosterone of about 253 ng/dL (well below the normal range) and reached an average of 604 ng/dL after six weeks. That’s roughly a 2.4-fold increase, bringing levels solidly into the normal range for adult men. Since low testosterone is one of the most common hormonal causes of reduced sexual desire in men, restoring it to healthy levels often improves libido as a downstream effect.
Why It Preserves Libido Better Than Clomiphene
Enclomiphene is the isolated trans-isomer of clomiphene (Clomid), a medication that’s been used off-label for male hypogonadism for decades. Standard clomiphene contains two isomers: enclomiphene, which blocks estrogen, and zuclomiphene, which actually activates estrogen receptors. That dual action is a problem. While clomiphene does raise testosterone, the zuclomiphene component can push estrogen-related side effects in the wrong direction, and one of the most commonly reported is decreased libido.
Clinical data makes the difference clear. In a comparative study, 33.3% of men taking clomiphene reported decreased libido, compared to just 8.6% of men taking enclomiphene. Regression analysis confirmed this wasn’t a fluke: men on enclomiphene were roughly 82% less likely to experience a drop in sexual desire than those on clomiphene. The likely explanation is estrogen levels. Clomiphene raised estradiol (the primary form of estrogen in men) by a median of 17.5 pg/mL, while enclomiphene actually lowered it by about 6 pg/mL. Excessive estrogen in men is associated with reduced sexual desire, breast tissue growth, and mood changes, so keeping it in check matters for how you feel day to day.
What This Means for Sexual Function
The relationship between testosterone and libido isn’t perfectly linear. Below a certain threshold (roughly 300 ng/dL, though it varies by individual), sexual desire tends to drop noticeably. Raising testosterone back into the normal range often restores it. But pushing testosterone from, say, 500 to 700 ng/dL doesn’t reliably produce a proportional boost in desire. So the men most likely to notice a libido improvement from enclomiphene are those starting with genuinely low levels.
It’s also worth noting that libido is more complex than a single hormone number. Sleep, stress, relationship dynamics, mental health, and other medications all play roles. Enclomiphene addresses one piece of the puzzle. Men with secondary hypogonadism often report a cluster of symptoms alongside low desire: fatigue, depressed mood, difficulty concentrating, and loss of muscle mass. Restoring testosterone can improve several of these simultaneously, which may contribute to feeling more like yourself overall.
How It Compares to Testosterone Replacement
Testosterone replacement therapy (injections, gels, or patches) is the most direct way to raise testosterone and typically improves libido reliably. But it comes with a significant tradeoff: external testosterone shuts down the body’s own production, which suppresses sperm count, sometimes to zero. For men who want to preserve fertility, this is a dealbreaker.
Enclomiphene works in the opposite direction. Because it stimulates the body’s own production pathway, it maintains or even improves sperm parameters. In a retrospective study, men treated with enclomiphene showed improvements in both sperm motility and total motile sperm count, outcomes that testosterone replacement cannot offer. This makes enclomiphene a particularly appealing option for younger men or anyone planning to have children.
Timeline for Noticing Changes
Testosterone levels begin rising within the first week or two of treatment, but the downstream effects on libido, energy, and mood take longer to materialize. Most clinical studies measure outcomes at the six-week mark or later, and that aligns with what many men report anecdotally: gradual improvement over the first one to two months rather than an immediate shift. Fertility-related benefits, like improved sperm motility, generally require at least three months of consistent use.
Regulatory Status and Access
Enclomiphene is not FDA-approved as a standalone medication. Its development as a branded drug (under the name Androxal) was discontinued in 2021. However, because enclomiphene is a component of FDA-approved clomiphene, it can be legally compounded by pharmacies under federal compounding regulations. This means access typically requires a prescription from a provider who orders it through a compounding pharmacy. The doses studied in clinical trials range from 12.5 to 25 mg daily, with 25 mg being the most commonly studied for hypogonadism.
Because it exists in a regulatory gray area, quality can vary between compounding pharmacies. Enclomiphene is also on the World Anti-Doping Agency’s prohibited list and the Department of Defense’s prohibited list, so competitive athletes and military personnel should be aware of testing implications.